Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 20 of about 67 for Genentech
Company Exchange Symbol Last price Quote change Market cap
PDL BioPharma Inc NASDAQ PDLI 5.82 +0.06 (1.04%) 955.02M
PDL BioPharma, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Biogen Inc NASDAQ BIIB 318.78 +1.78 (0.56%) 74.97B
Biogen Inc., formerly Biogen Idec Inc., is a global biopharmaceutical company. The Company is focused on discovering, developing, manufacturing and ...
Array Biopharma Inc NASDAQ ARRY 5.81 +0.06 (1.04%) 824.28M
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
ImmunoGen, Inc. NASDAQ IMGN 18.02 +0.12 (0.67%) 1.55B
ImmunoGen, Inc. is a biotechnology company. The Company develops targeted anticancer therapeutics. The Company has three wholly-owned product candidates in ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 5.25 -0.05 (-0.89%)
ARRAY BIOPHARMA DL-,001 FRA AR2 5.25 +0.10 (1.92%)
BIOGEN INC. DL -,0005 FRA IDP 290.02 -1.48 (-0.51%)
BIOGEN INC. DL -,0005 ETR IDP 288.45 -3.20 (-1.10%)
Biogen Idec SWX BIIB 307.50
IMMUNOGEN INC. DL-,01 FRA IMU 16.67 +0.57 (3.52%)
Exelixis, Inc. NASDAQ EXEL 5.73 +0.19 (3.43%) 1.27B
Exelixis Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
SPDR S&P Emerging Middle Est & Afrca ETF NYSEARCA GAF 64.05 -0.63 (-0.97%) 45.27M
SPDR S&P Emerging Middle East & Africa ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI Middle ...
SPDR EURO STOXX 50 ETF NYSEARCA FEZ 38.58 +0.28 (0.73%) 3.31B
SPDR EURO STOXX 50 ETF (the Fund) seeks to replicate as closely as possible the price and yield of the EURO STOXX 50 Index (the Index).
SPDR DJ Wilshire Global Real Estate(ETF) NYSEARCA RWO 47.59 +0.29 (0.61%) 2.01B
SPDR Dow Jones Global Real Estate ETF (the Fund), formerly SPDR DJ Wilshire Global Real Estate ETF, seeks to replicate as closely as possible the price and ...
SPDR S&P China (ETF) NYSEARCA GXC 79.30 -0.37 (-0.46%) 1.05B
SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index).
NewLink Genetics Corp NASDAQ NLNK 52.15 +0.99 (1.94%) 1.49B
NewLink Genetics Corporation (NewLink) is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for ...
SPDR S&P Emerging Latin America (ETF) NYSEARCA GML 43.81 +0.53 (1.22%) 30.67M
SPDR S&P Emerging Latin America ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI Latin America ...
SPDR Dow Jones Interntnl Real Estate ETF NYSEARCA RWX 42.28 +0.12 (0.28%) 5.16B
SPDR Dow Jones International Real Estate ETF (the Fund), formerly SPDR DJ Wilshire International Real Estate ETF, seeks to closely match the returns and ...